For example, optimal warfarin dosing is known to be dependent on variants in CYP2C9 in addition to VKORC1 [78] and variants in the ADME gene UGT1A1 are documented to contribute to different responses to the cancer drug irinotecan around the globe [79]. The gene discussed is VKORC1; the disease is cancer.